Comparison of carbon ion and photon reirradiation for recurrent glioblastoma.

Strahlenther Onkol · 2022 · PMC9038837 · PMID 34523017

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendp = 0.063so close (0.05 < p ≤ 0.1)

Progression-free survival Univariate analysis of the whole collective and of the matched-pair group showed a trend towards better progression-free survival for the patients treated with CIRT (5.5 months vs. 3.9 months, p = 0.063; for the propensity score-matched group 5.7 months vs. 3.9 months, p = 0.085).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.